Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve.
about
Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsComparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.Antimicrobial activity of human pancreatic juice and its interaction with antibiotics.Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers.Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteersComparison of antibiotic activities by using serum bactericidal activity over time.Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimensDevelopment of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similarPharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteersStandardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.Serum bactericidal testSerum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate.Role of pharmacokinetics in the outcome of infections.Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.
P2860
Q33740774-BD8DB43C-15CD-426A-92D6-D577CB07A78DQ33983513-3EAEBB51-7DEA-47CB-9E0C-DB3DEF3E081EQ35117021-57A78545-E951-4E92-AB7A-018A07085151Q35121273-588670B8-15F4-419F-B9CD-7915EEA09F9CQ35121441-669AAD87-4CB7-4412-8608-418E4F58017FQ35123123-E129450F-74C9-4C7D-B6A7-FC02C75A5069Q35123139-57731D69-9F41-4329-9A7E-4EA6FB2762D7Q35126768-CB642C4C-D589-4D77-9B4C-9B5805CC3297Q35136125-572E394B-5B05-469E-8B22-C3A075E4482CQ35139002-A3D9D165-2DAD-4AED-A78F-E8EC268F1981Q35258426-E2E57B39-3BF6-4C73-B3C6-6488C6DF68E6Q35294133-40474B65-9878-4C5A-8E1E-0B67664A24A0Q35564407-389187D8-8BCC-4E89-899C-C031A2AE8D1AQ35565851-FC715EBB-00A2-4A28-A67D-72E0FB695CBBQ35814771-CAA76D50-BDEF-478A-9675-8D74BB3C6DFAQ35814807-415458FC-DA6C-4FBD-9E19-99C9CB7571D3Q35822946-1512C5B6-72A4-42C1-A067-2412DDE718B1Q35897492-BF83BC37-93DE-42B4-9E74-53842ECE9DFCQ36072639-579DCBEA-9135-444C-8A22-2449F06FC5A9Q36632471-786BEF5E-F65E-4FB9-8242-7E7BA144F5E0Q36757852-36A53AAF-B355-4FA3-B1F3-16A2A459B1F5Q39639407-4824C7DB-0D9D-400A-9DBE-7044CB568C9FQ52231066-575400A4-707F-4B8E-84D1-32139AAE7C4F
P2860
Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Analysis of a new method for a ...... e bactericidal activity curve.
@en
Analysis of a new method for a ...... e bactericidal activity curve.
@nl
type
label
Analysis of a new method for a ...... e bactericidal activity curve.
@en
Analysis of a new method for a ...... e bactericidal activity curve.
@nl
prefLabel
Analysis of a new method for a ...... e bactericidal activity curve.
@en
Analysis of a new method for a ...... e bactericidal activity curve.
@nl
P2093
P356
P1476
Analysis of a new method for a ...... e bactericidal activity curve.
@en
P2093
Barriere SL
Gambertoglio JG
Kapusnik JE
P356
10.1093/JAC/16.1.49
P407
P577
1985-07-01T00:00:00Z